Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Invasive fungal infections following liver transplantations. Risk factors, incidence, treatment and outcome

M Pacholczyk, , B Łągiewska

Ann Transplant 2009; 14(1): 16-17 :: ID: 880253

Abstract

Background: The incidence of invasive fungal infections (IFI), particularly invasive candidiasis and aspergillosis following solid organ transplantation vary from 1.4% to 42%. IFI the most commonly occurs after liver transplantation (OLT), lung and hearth transplantation and combined pancreas and kidney transplantation. But the etiology of this infection is different in case of hearth transplantation (dominating aspergillosis), liver transplantation (almost equal aspergillosis and candidiasis) and pancreatic transplant (dominating candidiasis). Mortality related to IFI is dependent of the type of transplant and vary from 3 to 100% of cases. The results of the treatment very much depend of the time of diagnosis and early start of selected therapy. Therefore the diagnosis has to be based on clinical data and suspicions based on known risk factors. It is very well known which factors contribute to IFI episodes. So far multiple factors are listed; among them: immunodeficiency, type and time of surgical procedure, type of anastomosis (i.e. biliary anastomosis), intraoperative blood lost, rate of rejection, presence of central venous access and retransplantation were documented by many authors over the last years. The other analyzed independent factors described by other authors were thrombocytopenia (represents subgroup of liver transplant patients susceptible to early major infections) and hepatic iron overload.
Material/Methods: The incidence of fungal infection at our institution was  assessed over the time period from July'2000 to December'2007. The retrospective analysis of 208 consecutive OLT was undertaken to evaluate incidence, risk factors, clinical course, and outcome of fungal infections. 39 recipients out of the study group (18.7%) were transplanted as HU cases and 7 (3.4%) received the second transplant. Piperacylin/Tazobactam or Imipenem (in urgent transplantation) were used as standard antibiotic perioperative prophylaxis. All OLT recipients received Flukonazol perioperatively for10 to 14 days. Selective digestive decontamination (SDD) is used routinely at our institution (consist of Amikin and Nystatine).
Results: Infections involving Aspergillus (6 cases), Candida (22 cases), Pneumocystis carini (1 case) and Cryptococcus (1 case) were observed in 15.4% (32/208) of our recipients. Except for two cases (Cryptococcus encephalitis at 3 months following OLTx and Pneumocystis carini pneumonia 2 months after OLTx) all of the episodes (30) developed during the first postoperative month. All cases of lung aspergillosis (6 cases) developed in patients with longstanding cholestasis prior to transplantation. In one case additionally post transplant extra hepatic bile duct necrosis requiring reconstruction of biliary anastomosis preceded pneumonia (Aspergillus). In 3 cases pulses of methyl-prednisolone were used for episode of acute rejection. Apart from that, none of the potential risk factors for fungal infections described by other authors was noted in our patients. 5 out of 6 aspergillosis cases survived on combined (2 drugs) antifungal therapy. Recipient diagnosed Cryptococcus encephalitis died. All cases with UTI (18)/ respiratory (6) candidiasis survived.
Conclusions: Early diagnosis and prompt treatment is detrimental for patient's survival.

Keywords: Transplantation, Organ Transplantation

Add Comment 0 Comments

In Press

08 Mar 2024 : Original article  

Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...

Ann Transplant In Press; DOI: 10.12659/AOT.943532  

14 Mar 2024 : Original article  

Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort Study

Ann Transplant In Press; DOI: 10.12659/AOT.943652  

14 Mar 2024 : Case report  

Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...

Ann Transplant In Press; DOI: 10.12659/AOT.942358  

15 Mar 2024 : Review article  

Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...

Ann Transplant In Press; DOI: 10.12659/AOT.941185  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358